Login to Your Account



Elan Moves ELND005 into Phase III, Nixes Drug Delivery

By Cormac Sheridan


Wednesday, August 11, 2010
DUBLIN, Ireland – Elan Corp. plc has decided against spinning out its drug delivery arm, Elan Drug Technologies (EDT), into a separate business after concluding that "market conditions at this time are not conducive to an appropriate valuation." (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription